Oda S, Shimoda M, Yamada S, Sato O, Tsugane R
Department of Neurosurgery, Tokai University School of Medicine.
No Shinkei Geka. 1992 Dec;20(12):1241-6.
Sixty-three patients (aged from 4 to 75 years) who had suffered severe head injury or cerebrovascular disease were placed on barbiturate regimens in which intravenous administration was given in amounts of 1-4 mg/kg/hr. Dobutamine and dopamine were also administered to prevent cardiac failure and renal failure. Immediate and delayed complications caused by barbiturate therapy were investigated and analyzed. Immediate complications included tachycardia which was seen in 16 cases (25%), and hypotension in 14 cases (22%), respectively. Higher incidence of those complications was noted among the patients who underwent surgery. Delayed complications included hypokalemia (41 cases, 65%), liver dysfunction hypernatremia (24 cases, 38%), infection (21 cases, 33%), cardiac failure (8 cases, 13%) and renal failure (1 case, 2%), respectively. Therefore, in patients treated under barbiturate regimens great care should be taken in order to avoid above mentioned complications.
63例(年龄4至75岁)遭受严重头部损伤或脑血管疾病的患者接受了巴比妥类药物治疗方案,静脉给药剂量为1 - 4毫克/千克/小时。同时给予多巴酚丁胺和多巴胺以预防心力衰竭和肾衰竭。对巴比妥类药物治疗引起的即时和延迟并发症进行了调查和分析。即时并发症包括心动过速,16例(25%)出现;低血压,14例(22%)出现。这些并发症在接受手术的患者中发生率更高。延迟并发症分别包括低钾血症(41例,65%)、肝功能障碍高钠血症(24例,38%)、感染(21例,33%)、心力衰竭(8例,13%)和肾衰竭(1例,2%)。因此,在接受巴比妥类药物治疗方案的患者中,应格外小心以避免上述并发症。